000 | 01958 a2200577 4500 | ||
---|---|---|---|
005 | 20250513204351.0 | ||
264 | 0 | _c20000501 | |
008 | 200005s 0 0 eng d | ||
022 | _a0066-4804 | ||
024 | 7 |
_a10.1128/AAC.44.4.978-984.2000 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrophy, D F | |
245 | 0 | 0 |
_aPharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _cApr 2000 |
||
300 |
_a978-84 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 | _aBreath Tests |
650 | 0 | 4 | _aCarbamates |
650 | 0 | 4 |
_aClarithromycin _xadverse effects |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aCytochrome P-450 CYP3A |
650 | 0 | 4 | _aCytochrome P-450 Enzyme Inhibitors |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aErythromycin |
650 | 0 | 4 | _aFurans |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLiver Function Tests |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMixed Function Oxygenases _xantagonists & inhibitors |
650 | 0 | 4 |
_aSulfonamides _xadverse effects |
700 | 1 | _aIsrael, D S | |
700 | 1 | _aPastor, A | |
700 | 1 | _aGillotin, C | |
700 | 1 | _aChittick, G E | |
700 | 1 | _aSymonds, W T | |
700 | 1 | _aLou, Y | |
700 | 1 | _aSadler, B M | |
700 | 1 | _aPolk, R E | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 44 _gno. 4 _gp. 978-84 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.44.4.978-984.2000 _zAvailable from publisher's website |
999 |
_c10676328 _d10676328 |